Publish Date :2017-08-29
A Swiss pharma giant, Novartis will attempt a regulatory sanction this year with a new type of anti-inflammatory heart medicine, although some doctors fear critical infection hazards and a high cost may dominate the drug’s restricted bene...
Publish Date :2017-08-24
A new economic analysis has been rolled out by Amgen of Repatha’s Fourier, which is an outcome study that proved to be unsuccessful in the early stages to impress the market at the time of disclosure this year. The PCSK9 drug is said to b...
Publish Date :2017-08-23
GlaxoSmithKline’s Cervarix vaccine is losing the United States market and Europe market to Merck’s Gardasil vaccine, but it desires to acquire some tons from China market. To achieve that, they have established a partnership with Alibab...
Publish Date :2017-08-22
On Monday, the Los Angeles Superior Court jury ordered Johnson & Johnson to compensate USD 417 million to a lady who claimed that after using the Johnson & Johnson’s talc-based products such as Baby Powder for feminine hygiene, she develo...
Publish Date :2017-08-21
Unfortunate for Tesaro, Lynparza is now going to fight back. The drug by AstraZeneca which is now shared with Merck & Co has achieved its new approval which is broader in ovarian cancer in its race with the Zejula, a recent launch by Tesaro...
Publish Date :2017-08-21
A dental implant that consists of a reservoir for slow drug release has been developed by scientists. There have been tests conducted in a laboratory in which a strong antimicrobial drug was released slowly by the reservoir and reflected th...
Publish Date :2017-08-18
Biocon in India has pulled its application of EU for Herceptin biosimilar while it struggles to bring its manufacturing in place but confirmed presently that it should be in a situation to submit the paperwork again to the authorities in th...
Publish Date :2017-08-16
According to some researchers’ report, cancer patients have elevated risks of stroke and heart attack from blood clumps, particularly in the earlier months following diagnosis, compared with patients who don't have cancer.
Publish Date :2017-08-09
research team has found out that epithelial cells present in the eyes could aid in deterring the rampancy of Ebola virus. This research team includes investigators from Flinders University, Emory University and Australia’s CSIRO, who have...
Publish Date :2017-08-09
Allergan’s President and CEO Brent Saunders, exuberated confidence as he was asked regarding the best Pharma market in the world. He reciprocated saying that there is no contest whatsoever. However, he mentioned medical aesthetics to be t...